- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02677935
Impact of Peer Education Program on Headache Disorders
February 8, 2016 updated by: NMP Medical Research Institute
Impact of Peer Education Program on Headache Disorders in Rural Communities, India: a Quasi-experimental Study
Worldwide, headache disorders are among the most common medical conditions.
Many people with headache need not experience further pain if the diagnosis and treatment are correct.
Most patients do not have correct diagnosis and treatment.
This study tested a model for treatment of people with headache disorders at primary health-care level in rural areas of Haryana, India.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
360
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All residents of the Region Kaithal (haryana) may apply for recruitment
- Primary headache disorders including tension type headache, migraine
Exclusion Criteria:
- Planning to move the area
- Refused to consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
community support program
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Reduction in number of days per month with headache after 12 months
Time Frame: From baseline to 12 months
|
From baseline to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Reduction in number of days per month of over the counter drugs after 12 months
Time Frame: From Baseline to 12 Months
|
From Baseline to 12 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Deepa Rani, NMP Medical Research Institute
- Principal Investigator: Neeraj Kumar, Kaithal Hospital
- Study Director: Ram Sharma, NMP Medical Research Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2015
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
February 5, 2016
First Submitted That Met QC Criteria
February 8, 2016
First Posted (Estimate)
February 9, 2016
Study Record Updates
Last Update Posted (Estimate)
February 9, 2016
Last Update Submitted That Met QC Criteria
February 8, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- nmp/22182
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Headache Disorder
-
VR1 CorporationTerminatedPrimary Headache DisordersUnited States
-
Ankara City Hospital BilkentActive, not recruitingPrimary Headache DisorderTurkey
-
Aksaray University Training and Research HospitalCompleted
-
Stanford UniversityCompletedHeadache DisordersUnited States
-
Centre Hospitalier Universitaire de BesanconUnknownPrimary Headache DisorderFrance
-
University Hospital, GhentRecruitingMigraine Disorders | Headache Disorders | Tension-Type Headache | Cluster Headache | TACS | Secondary Headache DisorderBelgium
-
State University of New York at BuffaloCompletedSecondary Headache DisorderUnited States
-
Tartu University HospitalUniversity of TartuRecruitingMigraine | Primary Headache DisordersEstonia
-
Montefiore Medical CenterCompletedMigraine | Tension-type Headache | Primary Headache DisorderUnited States
-
Antonio Francesco UrbinoScuola Superiore di Osteopatia ItalianaUnknownHeadache Disorders | Primary Headache DisorderItaly
Clinical Trials on Community education programs
-
Assistance Publique Hopitaux De MarseilleCompletedType 1 Diabetes in AdolescenceFrance
-
Sansum Diabetes Research InstituteAbbott; DexCom, Inc.RecruitingCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
Rigshospitalet, DenmarkSteno Diabetes Center Sjaelland; Center for Clinical Research and PreventionRecruitingCardiovascular Diseases | Diabetes Mellitus, Type 2 | ObeseDenmark
-
Case Comprehensive Cancer CenterRecruiting
-
University Medicine GreifswaldNot yet recruiting
-
University of Texas at AustinPerrigo CompanyNot yet recruitingCovid19 | Food Insecurity | Children, OnlyUnited States
-
National Institute of Environmental Health Sciences...Environmental Protection Agency (EPA)Completed
-
Tufts UniversityCompleted
-
University of Maryland, College ParkCompletedInformation Dissemination | Evidence-Based Public HealthUnited States
-
London Health Sciences CentreUnknown